Concept Life Sciences names scientific board members

Concept Life Sciences Ltd, a UK drug discovery, development and manufacturing organisation, has appointed Luke O’Neill and Shane Liddelow to its scientific advisory board. Professor O’Neill is an immunologist and chair of biochemistry at Trinity College Dublin, Ireland while Dr Liddelow is an associate professor at NYU Langone Medical Center, US, specialising in neurodegenerative diseases. The two new members join Ian Waddell, who has 27 years of experience in drug discovery, and who was appointed to the board of directors in 2024. Concept Life Sciences recently made investments and an acquisition, of Charnwood Discovery, which completed at the end of 2024 to strengthen its provision of integrated services, particularly for complex drug discovery, and accelerate drug candidates to clinic.

Concept Life Sciences announced the appointment on 15 April 2025.